Unknown

Dataset Information

0

Metabolomics for predicting hyperglycemia in pregnancy: a protocol for a systematic review and potential meta-analysis.


ABSTRACT:

Background

Hyperglycemia in pregnancy (HIP) has been recently differentiated between diabetes in pregnancy (DIP) and gestational diabetes mellitus (GDM). The proposed protocol is relevant, and clinical concern is due to the higher risk of adverse pregnancy outcomes (APO) and long-term effects on both the mother and the fetus. Fasting plasma glucose level (FPG) and oral glucose tolerance test (OGTT) are current diagnostic tools. However, controversy persists concerning diagnostic criteria, cut-off points, and even selective or universal screening. The objective of this systematic review is to assess the performance of metabolomic markers in the prediction of HIP.

Methods

This is a protocol for a systematic review with potential meta-analysis. The primary outcome is GDM, defined as glucose intolerance identified in the second and third trimesters of pregnancy (any FPG ??92?mg/dL and DiscussionThis systematic review may have the potential to provide significant evidence-based findings on the prediction performance of metabolomics. There are short and long-term repercussions for the mother and the newborn. Therefore, both may benefit from an accurate prediction technique for HIP.

Systematic review registration

This protocol was registered in the PROSPERO platform under number CRD42018100175 .

SUBMITTER: Nicolosi BF 

PROVIDER: S-EPMC6708156 | biostudies-literature | 2019 Aug

REPOSITORIES: biostudies-literature

altmetric image

Publications

Metabolomics for predicting hyperglycemia in pregnancy: a protocol for a systematic review and potential meta-analysis.

Nicolosi Bianca Fioravanti BF   Leite Debora F DF   Mayrink Jussara J   Souza Renato T RT   Cecatti José Guilherme JG   Calderon Iracema de Mattos Paranhos IMP  

Systematic reviews 20190824 1


<h4>Background</h4>Hyperglycemia in pregnancy (HIP) has been recently differentiated between diabetes in pregnancy (DIP) and gestational diabetes mellitus (GDM). The proposed protocol is relevant, and clinical concern is due to the higher risk of adverse pregnancy outcomes (APO) and long-term effects on both the mother and the fetus. Fasting plasma glucose level (FPG) and oral glucose tolerance test (OGTT) are current diagnostic tools. However, controversy persists concerning diagnostic criteria  ...[more]

Similar Datasets

| S-EPMC7778786 | biostudies-literature
| S-EPMC6286473 | biostudies-literature
| S-EPMC6429842 | biostudies-literature
| S-EPMC3913632 | biostudies-literature
| S-EPMC6089264 | biostudies-literature
| 79216 | ecrin-mdr-crc
| S-EPMC7333799 | biostudies-literature
| S-EPMC9172055 | biostudies-literature
| S-EPMC6319778 | biostudies-other
| S-EPMC6612152 | biostudies-literature